C84.73
Anaplastic large cell lymphoma, ALK-negative, intra-abdominal lymph nodes
Clinical Classification Guidelines
Medical Intelligence & Overview
Anaplastic large cell lymphoma (ALCL) is a type of non-Hodgkin lymphoma, a cancer that originates in the lymphatic system. Specifically, ALK-negative intra-abdominal lymph node lymphoma indicates that the disease affects lymph nodes within the abdominal area and does not have anaplastic lymphoma kinase (ALK) protein expression. This form of lymphoma is less common than ALK-positive ALCL and tends to affect adults more frequently. Recognizing and understanding this condition can help in timely diagnosis and management.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting immune system cells Chronic immune stimulation or inflammation Exposure to certain chemicals or infectious agents (less common)
Key Symptoms: Swelling or painless lumps in the abdomen or groin Abdominal pain or discomfort Unexplained weight loss Fatigue or weakness Fever and night sweats Loss of appetite Digestive issues such as nausea or bloating
Diagnostic & Treatment
Diagnosis Path: Physical examination focusing on lymph node swelling Imaging tests like CT scans or PET scans to locate enlarged lymph nodes Lymph node biopsy for microscopic examination and immunohistochemistry Blood tests to assess overall health and organ function Molecular studies to determine ALK status
Treatment Protocols: Chemotherapy regimens targeting lymphoma cells Targeted therapies that may focus on specific molecular characteristics Radiation therapy in select cases to control localized disease Stem cell transplantation in aggressive or refractory cases Supportive care to manage symptoms and improve quality of life
Clinical Advice & FAQs
Billing Guidance
Is C84.73 a billable ICD-10 code?
Yes, C84.73 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C84.73?
Clinical documentation must specify the nature of Anaplastic large cell lymphoma, ALK-negative, intra-abdominal lymph nodes and any associated comorbidities for accurate reporting.
Cite this Clinical Reference